• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症干细胞与人类恶性黑色素瘤

Cancer stem cells and human malignant melanoma.

作者信息

Schatton Tobias, Frank Markus H

机构信息

Transplantation Research Center, Children's Hospital Boston & Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

出版信息

Pigment Cell Melanoma Res. 2008 Feb;21(1):39-55. doi: 10.1111/j.1755-148X.2007.00427.x.

DOI:10.1111/j.1755-148X.2007.00427.x
PMID:18353142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2885609/
Abstract

Cancer stem cells (CSC) have been identified in hematological malignancies and several solid cancers. Similar to physiological stem cells, CSC are capable of self-renewal and differentiation and have the potential for indefinite proliferation, a function through which they may cause tumor growth. Although conventional anti-cancer treatments might eradicate most malignant cells in a tumor, they are potentially ineffective against chemoresistant CSC, which may ultimately be responsible for recurrence and progression. Human malignant melanoma is a highly aggressive and drug-resistant cancer. Detection of tumor heterogeneity, undifferentiated molecular signatures, and increased tumorigenicity of melanoma subsets with embryonic-like differentiation plasticity strongly suggest the presence and involvement of malignant melanoma stem cells (MMSC) in the initiation and propagation of this malignancy. Here, we review these findings in the context of functional properties ascribed to melanocyte stem cells and CSC in other cancers. We discuss the association of deregulated signaling pathways, genomic instability, and vasculogenic mimicry phenomena observed in melanoma subpopulations in light of the CSC concept. We propose that a subset of MMSC may be responsible for melanoma therapy-resistance, tumor invasiveness, and neoplastic progression and that targeted abrogation of a MMSC compartment could therefore ultimately lead to stable remissions and perhaps cures of metastatic melanoma.

摘要

癌症干细胞(CSC)已在血液系统恶性肿瘤和多种实体癌中被鉴定出来。与生理干细胞相似,癌症干细胞能够自我更新和分化,并具有无限增殖的潜力,它们可能通过这种功能导致肿瘤生长。尽管传统的抗癌治疗可能会根除肿瘤中的大多数恶性细胞,但它们对化疗耐药的癌症干细胞可能无效,而这些干细胞最终可能是复发和进展的原因。人类恶性黑色素瘤是一种极具侵袭性和耐药性的癌症。肿瘤异质性、未分化分子特征的检测,以及具有胚胎样分化可塑性的黑色素瘤亚群的肿瘤发生能力增加,强烈提示恶性黑色素瘤干细胞(MMSC)在这种恶性肿瘤的起始和传播中存在并发挥作用。在此,我们结合赋予黑素细胞干细胞和其他癌症中癌症干细胞的功能特性来综述这些发现。我们根据癌症干细胞的概念,讨论在黑色素瘤亚群中观察到的信号通路失调、基因组不稳定和血管生成拟态现象之间的关联。我们提出,一部分MMSC可能是黑色素瘤治疗耐药、肿瘤侵袭性和肿瘤进展的原因,因此,靶向消除MMSC区室最终可能导致转移性黑色素瘤的稳定缓解甚至治愈。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b85/2885609/7180d0c36fa5/nihms209140f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b85/2885609/7180d0c36fa5/nihms209140f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b85/2885609/7180d0c36fa5/nihms209140f1.jpg

相似文献

1
Cancer stem cells and human malignant melanoma.癌症干细胞与人类恶性黑色素瘤
Pigment Cell Melanoma Res. 2008 Feb;21(1):39-55. doi: 10.1111/j.1755-148X.2007.00427.x.
2
[Role of cancer stem cells in the progression and heterogeneity of melanoma].[癌症干细胞在黑色素瘤进展和异质性中的作用]
Orv Hetil. 2016 Aug;157(34):1339-48. doi: 10.1556/650.2016.30487.
3
Stem cells in melanoma development.黑色素瘤发展中的干细胞。
Cancer Lett. 2009 Jul 8;279(2):119-25. doi: 10.1016/j.canlet.2008.10.039. Epub 2008 Dec 17.
4
Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.代谢调节剂苯乙双胍在靶向黑色素瘤干细胞区室方面的治疗潜力。
Oncotarget. 2017 Jan 24;8(4):6914-6928. doi: 10.18632/oncotarget.14321.
5
TGF-β may control the switch between tumorigenic growth and "stem cell/mesenchymal" potentially drug-resistant states.转化生长因子-β(TGF-β)可能控制着致瘤性生长与“干细胞/间充质”潜在耐药状态之间的转换。
Dermatol Ther. 2015 May-Jun;28(3):177-8. doi: 10.1111/dth.12199. Epub 2015 Feb 3.
6
Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells. Hedgehog-GLI 信号通路驱动人黑色素瘤起始细胞的自我更新和致瘤性。
Stem Cells. 2012 Sep;30(9):1808-18. doi: 10.1002/stem.1160.
7
Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.黑色素瘤中癌症干细胞的细胞与分子生物学的治疗意义
Mol Cancer. 2017 Jan 30;16(1):7. doi: 10.1186/s12943-016-0578-3.
8
Melanoma stem cells.黑色素瘤干细胞
J Dtsch Dermatol Ges. 2015 Feb;13(2):118-24. doi: 10.1111/ddg.12584.
9
The human melanoma side population displays molecular and functional characteristics of enriched chemoresistance and tumorigenesis.人类黑色素瘤侧群表现出丰富的化疗耐药性和致瘤性的分子和功能特征。
PLoS One. 2013 Oct 3;8(10):e76550. doi: 10.1371/journal.pone.0076550. eCollection 2013.
10
Melanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator function.在神经嵴细胞条件下生长的黑素瘤球体是具有高度可塑性的迁移/侵袭性肿瘤细胞,具有免疫调节剂功能。
PLoS One. 2011 Apr 15;6(4):e18784. doi: 10.1371/journal.pone.0018784.

引用本文的文献

1
Confronting Melanoma Radioresistance: Mechanisms and Therapeutic Strategies.应对黑色素瘤放射抗性:机制与治疗策略
Cancers (Basel). 2025 Aug 14;17(16):2648. doi: 10.3390/cancers17162648.
2
Integrated spectroscopic and morphological analyses reveal cellular shifts in gene-silenced melanoma CSCs.综合光谱和形态学分析揭示了基因沉默的黑色素瘤癌症干细胞中的细胞变化。
Sci Rep. 2025 Aug 25;15(1):31175. doi: 10.1038/s41598-025-17155-2.
3
Modulating Cancer Stem Cell Characteristics in CD133+ Melanoma Cells through Hif1α, KLF4, and SHH Silencing.

本文引用的文献

1
In vitro expansion of immature melanoblasts and their ability to repopulate melanocyte stem cells in the hair follicle.未成熟黑素母细胞的体外扩增及其在毛囊中重新填充黑素细胞干细胞的能力。
J Invest Dermatol. 2008 Feb;128(2):408-20. doi: 10.1038/sj.jid.5700997. Epub 2007 Jul 26.
2
Generating quiescent stem cells.生成静止干细胞。
Pigment Cell Res. 2007 Aug;20(4):263-70. doi: 10.1111/j.1600-0749.2007.00388.x.
3
Immunosuppressive dendritic and regulatory T cells are upregulated in melanoma patients.免疫抑制性树突状细胞和调节性T细胞在黑色素瘤患者中上调。
通过沉默Hif1α、KLF4和SHH调节CD133 +黑色素瘤细胞中的癌症干细胞特性
ACS Omega. 2025 Apr 18;10(16):16804-16814. doi: 10.1021/acsomega.5c00799. eCollection 2025 Apr 29.
4
CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance.CD133 依赖性激活磷酸肌醇 3-激酶/AKT/雷帕霉素靶蛋白信号通路在黑色素瘤进展和耐药中的作用。
Cells. 2024 Jan 26;13(3):240. doi: 10.3390/cells13030240.
5
Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells.黑色素瘤进展及治疗耐药的机制:癌症干细胞样细胞的作用
Cancers (Basel). 2024 Jan 22;16(2):470. doi: 10.3390/cancers16020470.
6
The Potential of Epigallocatechin Gallate in Targeting Cancer Stem Cells: A Comprehensive Review.没食子酸表没食子儿茶素酯在靶向肿瘤干细胞中的潜力:全面综述。
Curr Med Chem. 2024;31(32):5255-5280. doi: 10.2174/0109298673281666231227053726.
7
Biomarkers and targeted therapy for cancer stem cells.癌症干细胞的生物标志物和靶向治疗。
Trends Pharmacol Sci. 2024 Jan;45(1):56-66. doi: 10.1016/j.tips.2023.11.006. Epub 2023 Dec 9.
8
Is Cutaneous T-Cell Lymphoma Caused by Ultraviolet Radiation? A Comparison of UV Mutational Signatures in Malignant Melanoma and Mycosis Fungoides.皮肤 T 细胞淋巴瘤是由紫外线辐射引起的吗?恶性黑色素瘤和蕈样肉芽肿中 UV 突变特征的比较。
Cells. 2023 Jun 13;12(12):1616. doi: 10.3390/cells12121616.
9
Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans-differentiation, and drug resistance.串联各点:黑素瘤细胞起源、肿瘤细胞可塑性、转分化和耐药性。
Pigment Cell Melanoma Res. 2023 Sep;36(5):330-347. doi: 10.1111/pcmr.13092. Epub 2023 May 3.
10
Hydrogel Microtumor Arrays to Evaluate Nanotherapeutics.水凝胶微肿瘤阵列评估纳米药物。
Adv Healthc Mater. 2023 Jun;12(14):e2201696. doi: 10.1002/adhm.202201696. Epub 2022 Nov 28.
Ann Surg Oncol. 2007 Oct;14(10):2854-60. doi: 10.1245/s10434-007-9488-3. Epub 2007 Jun 26.
4
Melanoma induces immunosuppression by up-regulating FOXP3(+) regulatory T cells.黑色素瘤通过上调FOXP3(+)调节性T细胞诱导免疫抑制。
J Surg Res. 2007 Jul;141(1):72-7. doi: 10.1016/j.jss.2007.03.053.
5
Identification of distinct changes in gene expression after modulation of melanoma tumor antigen p97 (melanotransferrin) in multiple models in vitro and in vivo.在多个体外和体内模型中对黑色素瘤肿瘤抗原p97(黑素转铁蛋白)进行调控后,鉴定基因表达的明显变化。
Carcinogenesis. 2007 Oct;28(10):2172-83. doi: 10.1093/carcin/bgm096. Epub 2007 Apr 21.
6
Angiogenesis: an organizing principle for drug discovery?血管生成:药物发现的一个组织原则?
Nat Rev Drug Discov. 2007 Apr;6(4):273-86. doi: 10.1038/nrd2115.
7
Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways.黑色素瘤需要由GLI1与RAS-MEK/AKT通路之间的相互作用所调控的HEDGEHOG-GLI信号传导。
Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5895-900. doi: 10.1073/pnas.0700776104. Epub 2007 Mar 28.
8
Serum osteopontin, an enhancer of tumor metastasis to bone, promotes B16 melanoma cell migration.血清骨桥蛋白是肿瘤向骨转移的增强剂,可促进B16黑色素瘤细胞迁移。
J Cell Biochem. 2007 Jul 1;101(4):979-86. doi: 10.1002/jcb.21298.
9
Reprogramming metastatic tumour cells with embryonic microenvironments.利用胚胎微环境对转移性肿瘤细胞进行重编程。
Nat Rev Cancer. 2007 Apr;7(4):246-55. doi: 10.1038/nrc2108.
10
Molecular definition of breast tumor heterogeneity.乳腺肿瘤异质性的分子定义。
Cancer Cell. 2007 Mar;11(3):259-73. doi: 10.1016/j.ccr.2007.01.013.